Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in India

Thomas Bollyky
The Atlantic
Apr. 14, 2013

Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?

It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.

Read More

All original InformationLiberation articles CC 4.0

About Us - Disclaimer - Privacy Policy